{"ticker": {"uuid": "b3926c1d-254a-448e-886d-48357c03782b", "symbol": "PBLS", "name": "Parabilis Medicines, Inc. Common Stock", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology"}, "articles": [{"title": "PBLS Stock: Price, Forecast, Financials & AI Analysis", "summary": "", "url": "https://news.google.com/rss/articles/CBMiSEFVX3lxTFBRX1hpTjljQTBPLTRQQXpNM0tDNzd3TkVneHRnMEwzSWhiMzJMNDBHV1lhWFZyNVZSbjJibEZBOFV5TE92aHpGSg?oc=5", "source_name": "Intellectia AI", "published_at": "2026-07-07T10:35:02+00:00", "published_display": "07 Jul 2026 10:35", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "guidance", "event_label": "Guidance", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Leerink Partners Initiates Parabilis Medicines(PBLS.US) With Buy Rating, Announces Target Price $40", "summary": "", "url": "https://news.google.com/rss/articles/CBMivgFBVV95cUxPTlhGcUE2THlTRWVQcmJxYkU1ZElfa05nTmRucE9QNzhiT1d3czltakFVYnh6ODlYRUxaeTcwMTN6LWdnYlVrRUNwdGF5X19id2lwSWxRdGlZVGQ5cF9ESFQ5QkxtSTVMRG5GWVpOT25iTnIyZXdoWG5oVFozQkh6S2d0OFdLSUNEajQ2UVI3Y2M1QnhFSUlDdmZGcjRVbDY4d04weXFBZzhyaldrX0c4b2dtWktvb3dEMW9kaVJn?oc=5", "source_name": "Moomoo", "published_at": "2026-07-06T20:17:48+00:00", "published_display": "06 Jul 2026 20:17", "sentiment": "positive", "sentiment_pct": 66, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Why Did Vir Biotechnology Stock Surge 60% After-Hours Today?", "summary": "", "url": "https://news.google.com/rss/articles/CBMiuwFBVV95cUxPSGpqV09Qc0RwZVU4cm1RODdrSUJFdWNYYmw5ZVNMTmhDRVhCTm15aTZSajhRckF6R194Q1hqTjZKQXJlbmJDMC1XT21TRDVfZ2xidWd4NzdxVE5oV1RURFhRMkFqajJUTnRQWm1GeUp6V1VJMzdKTzh0OGczWkp4M1VzdmR5Um43dVlSVnF2Tk1jTU9peTJvdkpHQUNjNlpSSmp0UEZwSWwzcnZZSUtJbVdiNnREOGtpaThF?oc=5", "source_name": "Stocktwits", "published_at": "2026-07-06T14:35:10+00:00", "published_display": "06 Jul 2026 14:35", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "This Parabilis Medicines Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday", "summary": "", "url": "https://news.google.com/rss/articles/CBMi4wFBVV95cUxNdGV6UUdmSEFiejZ6em5CanBGbmNEVXkya3ZraURrTU5JSnBlY29wUjRZU3U3Q1ZBRENTWXlZeUpxZGU0Yk5IV2JrMFQtbWRNbm9jb2dUbjZ5bHREWTBZN0dMMU5qamJhZlczUmI0NlZDWlIwV2wwc2ZKX1QweVJ6eUlpNGJVMDB5S0JJYTVORVBad3dUZmt6bGp6Rzc2UGdNU0RXS3MxWDZDRTdKSVpkeUtYOWJoWl9tX0p1TWpCWG4tUmNsYThLa1RGQWQzV1EtVDY0dlA3U1lKOWNSZUozYVktQQ?oc=5", "source_name": "Benzinga", "published_at": "2026-07-06T11:11:19+00:00", "published_display": "06 Jul 2026 11:11", "sentiment": "positive", "sentiment_pct": 66, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Guggenheim initiates Parabilis Medicines stock with buy rating", "summary": "", "url": "https://news.google.com/rss/articles/CBMi0AFBVV95cUxOeFRHVHJPejkydDF1MnowSlhFR25YcHROVFB5djI5RnUtZy1IX21Zc3Q0cmxyWThESHNSVnZrcEpfa3luZ2JqWFM5TUxPaEpmMVExM3lRanFRU2tRYzBfVl93MFRiR29zV0dXeDVybm02VDl6WTI0OG9kUFVFZGprTVFmZDQxZlB5Z0ZrRFphWHZNUTRuQzdsSFdEMlYybmNwRTFteGlsaTlXVmJNOEZoX3U5dXUwMlBsZ0h2VFhBUlJZNHZwRnFmTHE4Qy1HY2k1?oc=5", "source_name": "Investing.com UK", "published_at": "2026-07-06T07:51:29+00:00", "published_display": "06 Jul 2026 07:51", "sentiment": "positive", "sentiment_pct": 66, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Tenet Healthcare Stock Jumps As Analysts Hold Buy Ratings Into Earnings", "summary": "", "url": "https://news.google.com/rss/articles/CBMiiAFBVV95cUxNYzlxZUxqQXJsWHRaUDE4SE1xeXUySXpBalJOamFXdlpnOHdQU25fTVFSdGZlcENQX2tLU2ljMXlvNW8xSnFNcHhsYnhJZURQSWNueTR4cVItWVdxbXFOeDNWYVRfOG9rWGpBNUUwT2lBSHVkcFdMdnhEUzdycnczUms3a3dzSDk5?oc=5", "source_name": "timothysykes.com", "published_at": "2026-07-04T15:08:00+00:00", "published_display": "04 Jul 2026 15:08", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Parabilis Medicines Inc. (PBLS) Stock Price | Live Quotes & Charts | NASDAQ", "summary": "", "url": "https://news.google.com/rss/articles/CBMiTkFVX3lxTE9DMmdCU2lwTTVuVmdWby1iaXVIX28tLU42MkRReHYtSlRQWW1IOGxCa245UlFkSmN1N2lTd2FRZVJ6azVPR2Fpb1VzR2dMUQ?oc=5", "source_name": "StocksToTrade", "published_at": "2026-07-03T00:53:00+00:00", "published_display": "03 Jul 2026 00:53", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Why Tenet Healthcare (THC) Stock Is Up Today", "summary": "", "url": "https://news.google.com/rss/articles/CBMipgFBVV95cUxNTGpMSWYxM2M3RmxZNHFVMm5pTnNfeTZKNzNiWHFJRTBkUDYtMWJaOFB0ZUVKYldFclQ2WFdscFJKTjdHS25XZVpMRE9CRUlSU3NDS3hKTUtaamxpREN2LTAyc3AtdWdTZlhzZ3kzYmEtMEI5QjVGZ0VVdFN2R0dKUWh2Vm9FelByMUU5N0tXQk5OeU5ZZndqekVNeEJVbHVZVTNUdmFB?oc=5", "source_name": "TradingView", "published_at": "2026-07-02T15:31:03+00:00", "published_display": "02 Jul 2026 15:31", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Insider Stock Purchases: June 29, 2026", "summary": "", "url": "https://news.google.com/rss/articles/CBMigAFBVV95cUxOYzVmX0h1OEhfQ1hmSC1ncThJMm1WSzE1alJQRDV3cmhsNDh4aHFHeDJjUEd3WjVid05qeW5sYVdrWmhEb2RoOTdtNVA4bktxb0ZmOHpPS08xR201ek80Z214Rmdhbk4zOWtnbGdGcTJTbUdhLTBMeGhjcF9iMTd4Xw?oc=5", "source_name": "Quiver Quantitative", "published_at": "2026-06-29T18:45:00+00:00", "published_display": "29 Jun 2026 18:45", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "[Form 4] Parabilis Medicines, Inc. Insider Trading Activity", "summary": "", "url": "https://news.google.com/rss/articles/CBMiuAFBVV95cUxPSndZX3hzUGJ5cUdyZmJIUFQ2Y2tvdUZ5ZHlqWUdraWpxRmNTSksyRHpqUTJkS19hUXJrMk9YWVZBVGJIcDI2VTkweUJlSEZfNEw0Vlk3OXhNOHEzLVVzVFF3WG53UUZOWmtUNmJWbTU2b0Jodld0Q1U3VHRCRHNHY2EzekdMNE1RSU52aXVPdDBwT1NzZFBuUEswb1lpbHZtTmlxSm9zbmh6RG1STnFMaHdaSzhjNnJZ?oc=5", "source_name": "Stock Titan", "published_at": "2026-06-29T14:41:50+00:00", "published_display": "29 Jun 2026 14:41", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Parabilis Medicines (PBLS) holder reports 527,070-share Series F position", "summary": "", "url": "https://news.google.com/rss/articles/CBMiywFBVV95cUxNcTBYMWg5TGUtazRUMHZ0X2lxSFJHc3Z6em5yOVJtS0tscEZMdE5PcjdHYjZ0VHlNZlhZeV9seWZ0Q2RQNGkxSzFJRUFENHI3TVhwb25wUmZ5RmExWkZ1SFBzYWk0QzlWVHVYajRvXzJuRmNkRVRob1pCX1NDUXRaY0xBMEtLcGh5YU5CVU1aeDZ2WmtNYXpNTnFlWk8xRzRnb0pGanVpTFpReGhjTUVDWkQxQ0xMNy1ucVl2VXp6STM0OFdzQW1Kc1Fidw?oc=5", "source_name": "Stock Titan", "published_at": "2026-06-29T14:38:50+00:00", "published_display": "29 Jun 2026 14:38", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Fresh Off IPO, A Director Buys $474,000 of Parabilis Medicines Stock. Is PBLS a Buy?", "summary": "", "url": "https://news.google.com/rss/articles/CBMizgFBVV95cUxOUzE5ZXV6WDUwS3hpSXZ2cUF1aGZnaE1nWmFiaE1fdWI1d2pDaXUxNE44MGs5c1ZrZVdrVkp3ai00bUZzcHNiMGNiNGhYZFpFazBkeHdnbmptdFJscXJFTmxKMURodElCS19PdkJ2WDNyLUp4NmtSRFgwRHd5cjltOUwwYk9XdDhteldnY0VjUG96MTA4WXFFSXIyWU8wNXBkaER2RkR4MFRNcTFsNHR2X2hsRktZNEFvRnhOcEFiNVVRMnBxVHRNakFSUGFiZw?oc=5", "source_name": "The Motley Fool", "published_at": "2026-06-20T07:00:00+00:00", "published_display": "20 Jun 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "[SCHEDULE 13D] Parabilis Medicines, Inc. Major Shareholder Acquisition (>5%)", "summary": "", "url": "https://news.google.com/rss/articles/CBMiygFBVV95cUxOMTBlV3Jid2NNUUF2ajM1Q0lxUDVBaUZRazU5R1drRFVZYUo1Y0Y5Z1dzTU1abzdKMEVNel94WG5jdGM0ZjZJUmNOQzRUUjhKUHNEcFpoU3lVcWJTaXIyOGxLMXdXcWpDSzhDeC1HWERZeDFubWZfRldTWkJ5RE1iRjRwS1VlQnZDbGFOSmJUTzBmUTFMRjBpLWNIcUpVOVktTGU1OU9PdFFlbjRPTDc5X0dCdktBSHFSM3BSSGdZaG1fQkpzdHZBSXNn?oc=5", "source_name": "Stock Titan", "published_at": "2026-06-18T07:00:00+00:00", "published_display": "18 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Apothecary Capital, tied to Parabilis (PBLS) director, buys 17,500 shares", "summary": "", "url": "https://news.google.com/rss/articles/CBMiuAFBVV95cUxOM3dWQzlJMGNEMUJULUxCMkduZjlnb2FGbmhremZ2VVBKSjhGdWNHRzZ1b2hlTDZvc1FZOWMzdkczSU94V3J2a0xQTThLaGp4VF9QZTllSVBqMDJwbFJCZ3MtRGxrM01DYVRsR3ZoRzFjS05pRHEzQmstUHpmV3BiaDNTU21KQTZBbXM2VGRhdGViQzlPc3AtZ203YnlTTzJ6WlZoRV9lUG54Uy01WElXcDR0VGQxcEo5?oc=5", "source_name": "Stock Titan", "published_at": "2026-06-16T07:00:00+00:00", "published_display": "16 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cooper Companies Stock: Is COO Underperforming the Healthcare Sector?", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqwFBVV95cUxPWkdoUDRJdkh3QndoZ3J2OHBvOEJlMUFEYjc1X3pLZGFXUlJ6eS1iNXhpYzNyd1NSZGxPOUdDM0xnZW9RcS1kdWNwR0xydVFVcEFGVmhfWWF5SFhYTmR5dXM0cTRIUENtbTc5bUpuNTNZQ0h0QWhMbnZDdGpfYjRWM2c3SWlCOHVJYTVoaUdDYnk2cTRKWWZTZHFvXzZDMTFmOGRUUUhyX3J6RUE?oc=5", "source_name": "Market source", "published_at": "2026-06-16T07:00:00+00:00", "published_display": "16 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Parabilis (PBLS) director-linked LLC makes open-market buy of 12,500 shares", "summary": "", "url": "https://news.google.com/rss/articles/CBMiuAFBVV95cUxQblp5MkxTMXptR0MzQWZYckJBby1vZktRSERnUWQ4cFQ3bzF4Wk5PdG1tMlNjeXBNVFRvOWthNXRBUXFwV29DV3BhMnQzcW5WbUZaOUhjWFVVS29pSThrY1dwZ3VVb3lQY2lKdVdsNjVjTEhvaGYzTkdEZldXbWVjZFRXcFU3ZHg2MzJsLTJ0aDBDUEw1RldKc1JrTjJ1VDJraVVuTTMzcUN6aDJEWms3amwyNTFwWVpo?oc=5", "source_name": "Stock Titan", "published_at": "2026-06-15T07:00:00+00:00", "published_display": "15 Jun 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "RA Capital funds lift Parabilis Medicines (PBLS) common equity exposure", "summary": "", "url": "https://news.google.com/rss/articles/CBMiuAFBVV95cUxQYzRCN0hrRlViRm10Y1BhQm9PSVN1Z2xOS1hZUEYyY3UzQ2ppb1k3UnNmaGNwSTF1OWlGUGV2Q0hhQmt1RXVxUjJ6ZktRRGJBNjE2SjdsSHBoTU0xbFlkMDZlV0JKS0V6ZFhyUjljQ0NGdXU5NHFBX3ZQeWhOX0hNRm1jLURINnlUdC1SeGU1NVg2ak5kM3QybXlIdDRyYlg2YzVFM2RYamdTS1hqbDJobnJlQ05GbGtv?oc=5", "source_name": "Stock Titan", "published_at": "2026-06-15T07:00:00+00:00", "published_display": "15 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Parabilis Medicines (PBLS) director converts preferred stock into common around IPO", "summary": "", "url": "https://news.google.com/rss/articles/CBMiuAFBVV95cUxOdjBJUTN5YVF6N19wTGU0OFQwVzdZQ1ZrQzRhWHBmRTVUWlBVZWZ6UlJQYldPVUVSbUJUN3NwMHZLVV94VHVuaTlDOW1NZTlJM0RaQmtEZ3kxV2h3Z2Z1RlZ3enZlN01fNDNfTktsYlctdWZuZFBHbDlWV2hiRXF6NjZ5RjFJVWkwejJJZmlVbjZHZDB5T1BVaTVSQUFnOV80d3A2SmNBLWx3UDExMW5PeWxQTzVlMEs5?oc=5", "source_name": "Stock Titan", "published_at": "2026-06-15T07:00:00+00:00", "published_display": "15 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Parabilis Medicines (PBLS) director converts Series F preferred into common in IPO", "summary": "", "url": "https://news.google.com/rss/articles/CBMiuAFBVV95cUxNNldIUXRFZEFaV09ua2NwNVl5LS1OeldaZkkzOURLd1FxNWxKR0NIVGxlX3RXVmh2RVNnLXhDWnhfcEFQd1o0RHo0aEpLa2dxcHEwUVdWc0NIamxUenRKbjVURGtSZzhYRUlDdUIyQUJ5Y0tYLWtFRW1DY1VlQnFMVTNKSXBYR0NPQTNLYXVNQVFEc1BMLTR3M2NwY25FZzU4dTFDNmdXSlJsNjZxTS11Mlo2UWg0bW40?oc=5", "source_name": "Stock Titan", "published_at": "2026-06-15T07:00:00+00:00", "published_display": "15 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Parabilis Medicines (PBLS) Stock Valuation After Recent 10% Single Day Decline", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqAFBVV95cUxQbU5qelItRGhjZkFHS29pMG9VMzA4WVBDNjZtaExhTXhiWU8yOWpuWEI5VzBWS2hmY2UzMTNQekJQOFVXR2NCZzBrTWpKaWFQLU1oaWJJc3dyanlMcFNMZi1TNE9IbndDMXViRmxJVDJJdjBKVk9rLWxYTDB6YjFwT1pOUzQ1TWdJcFFlbGhNb0ZwWWlzeG82TVVCbGgzUTJ4RUJJckVCNG8?oc=5", "source_name": "Market source", "published_at": "2026-06-15T07:00:00+00:00", "published_display": "15 Jun 2026 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Parabilis Medicines (PBLS) director granted 20,215 options at $20.00 strike", "summary": "", "url": "https://news.google.com/rss/articles/CBMiuAFBVV95cUxNaFVOQjhjQkIyblFfbGZHSlZndGhLVDVCVVd2MGg2MlZycTY3U0pEejhMdmFZY3l6emh6UVBNd1c2WU9idXN5Mk1Qa0M4aExlRmlra09iS2ZCNGJqdV9zUWQtbXZGZHNUcWN6OVZaVkNTNE9FZm9YMFZUOWtSZzhOdWlTMVRSclZHZUNuc29DM050a0I3WERzZVdXVnNPdmUwRmgzcXJxSWphRG9TRkVnWFdoOVpreVpy?oc=5", "source_name": "Stock Titan", "published_at": "2026-06-12T07:00:00+00:00", "published_display": "12 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Parabilis Medicines (PBLS) director receives stock options for 20,215 shares at $20", "summary": "", "url": "https://news.google.com/rss/articles/CBMiuAFBVV95cUxPZmtySDRGdGlMOGFoVEdCOFEyT1gyMkF2eVRTYlZaNEZwNi1vUEJuRExkRGVjNmNzYndXdGoxMjFfZDFkZzR6OGNBUnE1TF9WYkJtMmV0TTJfbjJ4LTdsUm84eWZHQ05TbWYwYjZOaGxvNzlxdEZTeGE3S0pZbmNjalFocTRlelk0Wmg4VXcyaGNyeUpIYjVaQ21uUF9saEJCYTk4Mk5oSFk1MHVuRTJmWFBDVWRSM2lV?oc=5", "source_name": "Stock Titan", "published_at": "2026-06-12T07:00:00+00:00", "published_display": "12 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Parabilis Medicines Closes Initial Public Offering", "summary": "", "url": "https://finance.yahoo.com/markets/stocks/articles/parabilis-medicines-closes-initial-public-203629656.html", "source_name": "MT Newswires", "published_at": "2026-06-11T20:36:29+00:00", "published_display": "11 Jun 2026 20:36", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Biotech Parabilis raises over $1.2B in 2026, backed by Regeneron", "summary": "", "url": "https://news.google.com/rss/articles/CBMiugFBVV95cUxObzROa3RHRU5zQmw2V3haRzJMRjZ2cTVqcExHTndkaHFtVExleFNuTzB1emJhV3g1TTJDWmxmLXAxODhYZEZnYUxGZXE2QVUzRmVXS2ZpRWlKNHVFaFp0MEZNMkVQUEFGSFN5WmxPb0VOWm5HQ0xLQmFTVVlCZWZtUElDVHZxa3g0TER3NWhjejVVb1ZUd2Z4RG56WU9MVXRyNE9aZGloeUFibThFaS1HMnAxWEQ1RV9Pd0E?oc=5", "source_name": "Stock Titan", "published_at": "2026-06-11T07:00:00+00:00", "published_display": "11 Jun 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Parabilis Medicines Announces Closing of Upsized Initial Public Offering, Including Full Exercise of Underwriters\u2019 Option to Purchase Additional Shares", "summary": "", "url": "https://news.google.com/rss/articles/CBMirwFBVV95cUxOUEtJT245cEdZRXFzeTV1c3lIS2hxSzF5cHpYdmdkSm9OV2pnelg3ZTFXbEdrTzlpNWR3UUo2d0RLYlVFbERaLXRJMFZsVUduajNqWVkzLWV4MThVajQ1WVZiWC1sS3ZUT3VpLWloeURRc3ZUSjkxYWFNeHlNME1kZ1FGYVc0aEllRmFvcDl0QkMwUzg2VDROOTBBOVpBbDlGWGh1N01UR2xOcWRMS05j?oc=5", "source_name": "Market source", "published_at": "2026-06-11T07:00:00+00:00", "published_display": "11 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "How to Play PBLS Stock After the Parabilis IPO", "summary": "", "url": "https://news.google.com/rss/articles/CBMilAFBVV95cUxOWnF5MlI3dkI0ZjdLZFJNazBwRFNMVTc2T2tnNDZsdnV5d20wUVV6QXZRQlpRVmVRMjIzX2Q4bEp1UkZoQU1fQzlIQlcwdnZJWjdESjdnSi1RbEdyMTB2YTk0ZDRIbzVLY3NJOVpMR3o0OEwweHJkWGEwSk9RZVN2SjA0UFpGbjJZYi1Dam02aTF1WVlo?oc=5", "source_name": "Barchart.com", "published_at": "2026-06-11T07:00:00+00:00", "published_display": "11 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Parabilis Reaches $3.7 Billion Market Cap on Frist Day Listed on NASDAQ", "summary": "", "url": "https://news.google.com/rss/articles/CBMijAFBVV95cUxOMHRoeHppV1hRakR2RkJEaHZDamxyb1Vyckg0Nk4wa3E5VFVOQ2dLYzNIdFRWQlBJa1ZEVTQtT2lPaUxScnEwUjJPeWw4R3pncmE5SUF5MEFBMTFiYnEyR29tb0l1VjFtUnBocGdIQWlnS3o1MTJuZWtNMThjSTBhMU1DOUg1SERQNHc5NA?oc=5", "source_name": "Pharmaceutical Executive", "published_at": "2026-06-11T07:00:00+00:00", "published_display": "11 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "PARABILIS MEDICINES (PBLS) Stock News & Updates", "summary": "", "url": "https://news.google.com/rss/articles/CBMiTkFVX3lxTFBHd2FyS016OUFuQUVEWXVCQzN6Y3FVRlZiVl9XOXZTeFZjVGhSc0xGY3VnQkhKa1RKclFocmJ6cjVTcjdmT0ttUS1FdHRKdw?oc=5", "source_name": "Stock Titan", "published_at": "2026-06-11T07:00:00+00:00", "published_display": "11 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "PARABILIS MEDICINES (PBLS) Stock Price, News & Analysis", "summary": "", "url": "https://news.google.com/rss/articles/CBMiU0FVX3lxTE83RmpwMXVzSU1fVThsMkhSR2FSVi0ydnFiRjYzMjRGc3p3SldfS3U3M2IzbWk1RXVKSTdFT1M1dTVzRzVBZWNsWmgwNktGY3dwUl9z?oc=5", "source_name": "Stock Titan", "published_at": "2026-06-11T07:00:00+00:00", "published_display": "11 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Parabilis Medicines to Raise $745 Million in IPO, Private Offering", "summary": "", "url": "https://finance.yahoo.com/markets/stocks/articles/parabilis-medicines-raise-745-million-100343602.html", "source_name": "MT Newswires", "published_at": "2026-06-10T10:03:43+00:00", "published_display": "10 Jun 2026 10:03", "sentiment": "positive", "sentiment_pct": 58, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "PBLS | Parabilis Medicines, Inc. Common Stock Data, Price & News", "summary": "", "url": "https://news.google.com/rss/articles/CBMiUEFVX3lxTE01d3hlU0V2SGMxOXd3LVo4SlN2alRhQnoyMEhtRHRRNVh1UGdVWXBqSGV2OXh2enhjNXZodUpySGVqTVlYQkh5VGtQaldHZktp?oc=5", "source_name": "Quiver Quantitative", "published_at": "2026-06-10T02:52:45+00:00", "published_display": "10 Jun 2026 02:52", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Drugmaker Parabilis Raises $745 Million in US IPO, Placement", "summary": "", "url": "https://news.google.com/rss/articles/CBMirgFBVV95cUxPWk9NMVlXMEZMemctdTZYbllzWDJENjd0OEE5VWh3VDlLRXgyNFp4NWhzSjlUM05PM3RvWEt4TU1iRjVNSjQwdDRTcHpQM0lyWGlrRE5vdkNkR2oxa3JCM2dKRlZ0QnEwWXdRTmplLUF2SDd4ZzJxNmFtQXhzNFdtS1c5UkFPdXY4UC1nbFdIS1BPM1dobHpMbkl3d1g3bWxIN1JMcFlsRTM2SVJKaXc?oc=5", "source_name": "Bloomberg.com", "published_at": "2026-06-09T07:00:00+00:00", "published_display": "09 Jun 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Parabilis Medicines Announces Pricing of Upsized Initial Public Offering", "summary": "", "url": "https://news.google.com/rss/articles/CBMirwFBVV95cUxQbHNwSkh4TWFlS0xrOUFrRzNHZUZ6V1hDZzRyN1V4aVEzYmdadmh6UlhSNmRCbTFrNHgwSlVWUWJOMnh1OHpaNkE4Y185LVBjMklfX3VNVFhhTWVzMlZLWG40NGtKMFBORlNSZnBkdUdIa2h3OHFQaXAzak1KWFVoTzNMUWd4ZWZlOUZ3Sy1WenJFYUxKVklEcUhxeldLdmZkYUl6TFoxZzQ0RHJKVDk4?oc=5", "source_name": "Market source", "published_at": "2026-06-09T07:00:00+00:00", "published_display": "09 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Parabilis Medicines targets $2.3 billion valuation in upsized US IPO", "summary": "", "url": "https://news.google.com/rss/articles/CBMiyAFBVV95cUxNSWg0QVVkWDZROWlCeEhXT05veEFkU0pRZ3JqcUNhdWRFb2hrUy1tRE1JelkzMDR6Tk1DVDNWV1NxSUZkUEtwbVNQVzFqT1ZlMzlWQUFTODI0dUxpSE8waHoySkw3dFdKbE1MekFBeTR4QzlFVmxCVFpzbWM0VWpnSjBodGczOUotcVZMNG9LcWc2N0tJRlI4RU5aU2tZMm5vZ0NGaUswRDFIMFJ6U0h2YXBYUXlVb0E5akZQOFdQc1JPOVYyZDE1VA?oc=5", "source_name": "Reuters", "published_at": "2026-06-09T07:00:00+00:00", "published_display": "09 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "symbol__ Stock Quote Price and Forecast", "summary": "", "url": "https://news.google.com/rss/articles/CBMiUEFVX3lxTE4xVVY3TFI3WF93SFNCTWU4YXRYa18zdkxxbWZIQlV6ZTVXNWItX0pBZzlVc2dTWHg2LTZBYzJISjktMjBxRlNYelY4Tkg4S1c3?oc=5", "source_name": "CNN", "published_at": "2026-06-05T20:49:49+00:00", "published_display": "05 Jun 2026 20:49", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "guidance", "event_label": "Guidance", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Parabilis Medicines aims to raise up to $475 million in US IPO", "summary": "", "url": "https://news.google.com/rss/articles/CBMiwgFBVV95cUxQcnZyenBRbkNCcl90TG5GeU5GVE8yM18wNDg1UFdISE5PUHl2VVZaRzN0MXgyWmVxOEpBd2tmaDRzNVRxS29aZzZfa1VkX0RLdW5BekR2c2g5Q3pLa25uWE1TdGZFcGNJS0g0REJTQ2VlVDNBYnBidXI1ZFFKVkJiNjJ0d0wyeDV5U2VMMDVyakdYMUVQOEZXcXA3VF9OVGZQX2hqdzZXTDdfbGV2eVR3Y1REUjNfZmlMWThSOWRmN2Fldw?oc=5", "source_name": "Reuters", "published_at": "2026-06-04T07:00:00+00:00", "published_display": "04 Jun 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Regeneron backed Parabilis seeks up to $476M in U.S. IPO", "summary": "", "url": "https://news.google.com/rss/articles/CBMiigFBVV95cUxPQ3BjNmZBM2N5OHdpZEFvN0Jhd3VveU5BWHZuc3ZMX1UwU25ueThnckFFT0tNWk1IM21nbFJZOHpodlRUZmtpU25rUkRYZEpSVU1FSmNJaUxtSWJmMFRVQXMtamJQX2hsd25BaXEyUlFoZ0ZnZmFpSE1XUGVFMVo4YmE3MmIxdl9YM1E?oc=5", "source_name": "Seeking Alpha", "published_at": "2026-06-04T07:00:00+00:00", "published_display": "04 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "UNH stock jumps on Q1 earnings beat and raised guidance to $18.25+", "summary": "", "url": "https://news.google.com/rss/articles/CBMimAFBVV95cUxPTEprdzNMNGZxdkg5Wll5MTlvS1dheXQybm14TERTcGVzcHQzY0llOEpTa0dpZ1hGdHVyNWZ2cFFiWmZRdkl1aUp4YVlTMVJxSDRzaEdzRFB1cW93QzdhSmNxcEZDMWhGX2F0ODJFcjY1Mk1kMVhLNnVJSUhVMHZpRjRtTHo2cXBvbVJ3a05SWlJNMUdrSzFPbA?oc=5", "source_name": "eciks.org", "published_at": "2026-05-26T07:00:00+00:00", "published_display": "26 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 84, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Regeneron backed Parabilis Medicines seeks U.S. IPO", "summary": "", "url": "https://news.google.com/rss/articles/CBMigwFBVV95cUxOTFJBMkJLUTRVUk9QXzdEWV9SSE5WNS1ZYjNNYkk3UEJaSGdZUHAxaUFYVEpaOGFPRV96aWdUeWZzUXo5RWs3clNuSTdGYkRFaVhDWnhNeVE0MnBoMFg1OGVSNDJRVGk5WUgyR0l3X3pVRXVfREExMDdKZU5UMklQMXJEOA?oc=5", "source_name": "Seeking Alpha", "published_at": "2026-05-20T07:00:00+00:00", "published_display": "20 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "There May Be Reason For Hope In Puma Biotechnology's (NASDAQ:PBYI) Disappointing Earnings", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-05-15T07:00:00+00:00", "published_display": "15 May 2026 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Puma Biotechnology's (NASDAQ:PBYI) Conservative Accounting Might Explain Soft Earnings", "summary": "", "url": "https://news.google.com/rss/articles/CBMirgFBVV95cUxNZXcyN1VKc0J0RTFtSER6TGRSZm8xSWs2c0paem5paDd3V0J1cjF6ajhFb29tRFpUWWpxYUhzZjFkSXhYQ0lBNTVlbTdCRERpSXNjaGpDajFPOVlpRS1qV2xHMTRHS2pjVVBZMWFfNzItWE9FeENtQ2duMUxVQm5kOG41eVlrNUpObXp2VlhfekdhMVh2X0hjN3ZFZThZNUdWakFLUXJ4aFBVN2JyR2c?oc=5", "source_name": "Market source", "published_at": "2026-05-14T07:00:00+00:00", "published_display": "14 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Earnings Update: Here's Why Analysts Just Lifted Their Puma Biotechnology, Inc. (NASDAQ:PBYI) Price Target To US$5.00", "summary": "", "url": "https://news.google.com/rss/articles/CBMingFBVV95cUxPSUN3RjZYMEJ2VUdKQjJpRkZaUXRzM2NTa05WWmlmWHJnZDlJeUpTdFM5Wmk0SUhjclU2dldTZFIyRmZZeGJSNGM2SUNiSGJSYjh1VjYyR0hPZ2FJbWdsbHExYlhwMW1HRTZ0NUxwQzU1b2g4MGpwSHdoMkdIOUtqOXBBYk92LVk2cEFZMzVISjB3c04ydVBEYWw2cVVsdw?oc=5", "source_name": "Market source", "published_at": "2026-05-11T07:00:00+00:00", "published_display": "11 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Q4 Earnings Highlights: Regeneron (NASDAQ:REGN) Vs The Rest Of The Biotechnology Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMirAFBVV95cUxNWW9GYm5uRzlBX2ZiZXA3RkdDXzJhaFd2N1ZwR21jaXhiRkZQSTNHT0hMaUFjSGl6VXZfOURKemF2bWlFS1hKTXBjZUw4amdVQ0I4QlVnNmFkY1VTQ25pUjBiZGNDUE9QdWdOZHAxV1I1ejN6UE9WdGpseUdrMVA5MXBXWXJmWDBkZUdWUkxpOURCdlZlbDlQR3M5cjAzaDFtakFNblRTa3c0Q1J6?oc=5", "source_name": "Market source", "published_at": "2026-04-25T07:00:00+00:00", "published_display": "25 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "UnitedHealth Group Stock Soars on Strong Earnings, Boosted Outlook", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqwFBVV95cUxOREJZdE9YcDdTNFFiaGZpWWhZdkFleGdCT0lkdlBXMk5MRXRJV3VGODItT052ZDhGNjNxM3JYaW5nTllpNW8yOVplVWdBQjZkTWNXWVNRZklWQi1PTU93MGotVWtEd2VhUVJyZFBEbXdwTDFrTUdGWXV0MHUyOXJ2a3lWclFQNE1TNzZGd3ZqTnJOdlRHRFp3aEgxOTJJcTdlYTJIYldJMTdlRFk?oc=5", "source_name": "Investopedia", "published_at": "2026-04-21T07:00:00+00:00", "published_display": "21 Apr 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Biotechnology Stocks Q3 Results: Benchmarking Natera (NASDAQ:NTRA)", "summary": "", "url": "https://news.google.com/rss/articles/CBMiswFBVV95cUxPZzZDSEhwNlVYQU9kNXBMMU5ia0FTU0RxRlYwb0I1RERNODN4N0VwRFZWMUY4ODh3eWNkTkp0UERreFlSTllocGk4a2ZKcGlJVjQ4d1dXWlNnYTc5UlNMZm4wc2xITjRQVzhRb3Z5LXllQmhvUHNIaXB3LXk1RUw1WnRPam9wcVE1MXFxSmVzVF9MVmRyMWIwdVkxS1N3MUJZUzByLWxrVDlSSUk4QnNsXzJYbw?oc=5", "source_name": "Market source", "published_at": "2026-04-21T07:00:00+00:00", "published_display": "21 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "How Much Is UnitedHealth Group Stock Expected to Move After Earnings?", "summary": "", "url": "https://news.google.com/rss/articles/CBMirwFBVV95cUxPZjhXN2wySGd0T0g2am9uTU9YZWFMdDV5d0pfWEw5SWFrR3hCbXdJTER5WEFOUWt1LW9kWDdOV2w3ZEhxOWtKeDQxMkc1ZWRBb0gyT095dkI0UmJhR1hubWtfNk5zS0t6ejBSbkpNZ2t5eXY0QUlBNmx5LVZzN3JWSzBTN1I4N2x3Sk9TRkpYMXV6bTNTUlZRSzctR041Wlh4Z2VTcHdGTFppTkx3VHVV?oc=5", "source_name": "Investopedia", "published_at": "2026-04-17T07:00:00+00:00", "published_display": "17 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "A Look Back at Biotechnology Stocks\u2019 Q4 Earnings: Incyte (NASDAQ:INCY) Vs The Rest Of The Pack", "summary": "", "url": "https://news.google.com/rss/articles/CBMipAFBVV95cUxNZXlTZHFHZVNxMktqZ0hVNURmdE1hUFpZZnlfdEVhMnVla2EyTWN6b2YwNkVhNllxUy1Bczl2a0ZUNk04Q3oyTEZSajdpMnFDVXJfRTlfLUdHQ05uS3FQZkhNWkJ0MDFENDJvRXR0ZGV1RDlYVmdWem96V29NeTg4YWRZWGNoMzM1emRoSExJbXdwZnJIWHpsYjVnT0FQVHZtUW5iVg?oc=5", "source_name": "Market source", "published_at": "2026-03-30T07:00:00+00:00", "published_display": "30 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Puma Biotechnology Stock Declines More Than 9% in a Month: Here's Why", "summary": "", "url": "https://news.google.com/rss/articles/CBMijAFBVV95cUxNTTJZRVF4TFNBb3BhMW9VUnBnMVZhenZLNlZJY3Ryc3pGZ3dhZXBDY3pId0I5NFdmVTdiR2EyNXNBZFFuQ1M2M3pUTlRZdXJkbGxaT29mWm4wTG5fU2RtV1hIZWRwZUVNb3BEbTZKX3NPRV9mZVpiY3JBZDdMSDRveW1Jb0lIVmRKLVlidA?oc=5", "source_name": "Market source", "published_at": "2026-03-18T07:00:00+00:00", "published_display": "18 Mar 2026 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Why Did Puma Biotechnology's Stock Plummet Despite Beating Q4 Estimates", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqgFBVV95cUxQUEQ4TXY0R1lWMTJIcEJySm5iaEl1UkJ6TDMxcUtQYVl3UmxYdlJnaElpdlJDLU0xTTRvT0dsellqX21Tc3lxWW9IbWxHMnFBZGlxajdnUUU2OTNVY0l3NUh0OExMUENwWGxqY1d5dXV3YmRDZm9IRzc1c3FjbUh2cGxvdEJMZ25lYXdjSUliZ0txSjVFOHJhUXNTajBLeVV0M3B4dDk4V3dfQQ?oc=5", "source_name": "Kavout | AI", "published_at": "2026-02-28T09:53:07+00:00", "published_display": "28 Feb 2026 09:53", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Vir Biotechnology Stock Skyrockets 65% on Positive Prostate Cancer Treatment Trial Results", "summary": "", "url": "https://news.google.com/rss/articles/CBMivwFBVV95cUxNeEtXZ1k1WGctLWZuX0tYZE5SLWN4MU5KUktLV3NobzVheFpoMkZhdFJrWTdNelAwWGxYZUswazZtMWFUaXEzY3k0QnI0TW9IMGc2UTNzUlNmR1JxZG1JbEpQM0N3N1p4blRjaGdvMExoZzJOYWF3Tk5hajJCTlprZ3dESTVEd0Y4TXhvcElNR3Bqemd3RmNKcGxwa2dSU2phak9paE53c0t3dVFVeGZic2liZ1I0UU80TEM2WUNlOA?oc=5", "source_name": "TIKR.com", "published_at": "2026-02-25T08:00:00+00:00", "published_display": "25 Feb 2026 08:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "This Small-Cap Biotech Stock Is Soaring 29% on Excitement Over Its Prostate Cancer Drug", "summary": "", "url": "https://news.google.com/rss/articles/CBMimwFBVV95cUxPSG1pQzVIRmhqTkhiWXozT29mTWM0UERfakxmOTZzdm5TZ24wZTVqLUpSWlFyWGVmYnlicGE3ZVYxOVotWU5naGM5aUZVakItUGJLTk1ZVE1mclRHd1N3N0FIWkV2TzFrT2lMNFRjcHhnVVBzTk5vNUFkLTgwNExtRWJYN1hVZzRkVjRlTktkNk1jcnpfQklCamN3NA?oc=5", "source_name": "Barron's", "published_at": "2026-02-24T08:00:00+00:00", "published_display": "24 Feb 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "With EPS Growth And More, Puma Biotechnology (NASDAQ:PBYI) Makes An Interesting Case", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2025-12-09T08:00:00+00:00", "published_display": "09 Dec 2025 08:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}], "by_tier": {"direct": [{"title": "PBLS Stock: Price, Forecast, Financials & AI Analysis", "summary": "", "url": "https://news.google.com/rss/articles/CBMiSEFVX3lxTFBRX1hpTjljQTBPLTRQQXpNM0tDNzd3TkVneHRnMEwzSWhiMzJMNDBHV1lhWFZyNVZSbjJibEZBOFV5TE92aHpGSg?oc=5", "source_name": "Intellectia AI", "published_at": "2026-07-07T10:35:02+00:00", "published_display": "07 Jul 2026 10:35", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "guidance", "event_label": "Guidance", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Leerink Partners Initiates Parabilis Medicines(PBLS.US) With Buy Rating, Announces Target Price $40", "summary": "", "url": "https://news.google.com/rss/articles/CBMivgFBVV95cUxPTlhGcUE2THlTRWVQcmJxYkU1ZElfa05nTmRucE9QNzhiT1d3czltakFVYnh6ODlYRUxaeTcwMTN6LWdnYlVrRUNwdGF5X19id2lwSWxRdGlZVGQ5cF9ESFQ5QkxtSTVMRG5GWVpOT25iTnIyZXdoWG5oVFozQkh6S2d0OFdLSUNEajQ2UVI3Y2M1QnhFSUlDdmZGcjRVbDY4d04weXFBZzhyaldrX0c4b2dtWktvb3dEMW9kaVJn?oc=5", "source_name": "Moomoo", "published_at": "2026-07-06T20:17:48+00:00", "published_display": "06 Jul 2026 20:17", "sentiment": "positive", "sentiment_pct": 66, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Why Did Vir Biotechnology Stock Surge 60% After-Hours Today?", "summary": "", "url": "https://news.google.com/rss/articles/CBMiuwFBVV95cUxPSGpqV09Qc0RwZVU4cm1RODdrSUJFdWNYYmw5ZVNMTmhDRVhCTm15aTZSajhRckF6R194Q1hqTjZKQXJlbmJDMC1XT21TRDVfZ2xidWd4NzdxVE5oV1RURFhRMkFqajJUTnRQWm1GeUp6V1VJMzdKTzh0OGczWkp4M1VzdmR5Um43dVlSVnF2Tk1jTU9peTJvdkpHQUNjNlpSSmp0UEZwSWwzcnZZSUtJbVdiNnREOGtpaThF?oc=5", "source_name": "Stocktwits", "published_at": "2026-07-06T14:35:10+00:00", "published_display": "06 Jul 2026 14:35", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "This Parabilis Medicines Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday", "summary": "", "url": "https://news.google.com/rss/articles/CBMi4wFBVV95cUxNdGV6UUdmSEFiejZ6em5CanBGbmNEVXkya3ZraURrTU5JSnBlY29wUjRZU3U3Q1ZBRENTWXlZeUpxZGU0Yk5IV2JrMFQtbWRNbm9jb2dUbjZ5bHREWTBZN0dMMU5qamJhZlczUmI0NlZDWlIwV2wwc2ZKX1QweVJ6eUlpNGJVMDB5S0JJYTVORVBad3dUZmt6bGp6Rzc2UGdNU0RXS3MxWDZDRTdKSVpkeUtYOWJoWl9tX0p1TWpCWG4tUmNsYThLa1RGQWQzV1EtVDY0dlA3U1lKOWNSZUozYVktQQ?oc=5", "source_name": "Benzinga", "published_at": "2026-07-06T11:11:19+00:00", "published_display": "06 Jul 2026 11:11", "sentiment": "positive", "sentiment_pct": 66, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Guggenheim initiates Parabilis Medicines stock with buy rating", "summary": "", "url": "https://news.google.com/rss/articles/CBMi0AFBVV95cUxOeFRHVHJPejkydDF1MnowSlhFR25YcHROVFB5djI5RnUtZy1IX21Zc3Q0cmxyWThESHNSVnZrcEpfa3luZ2JqWFM5TUxPaEpmMVExM3lRanFRU2tRYzBfVl93MFRiR29zV0dXeDVybm02VDl6WTI0OG9kUFVFZGprTVFmZDQxZlB5Z0ZrRFphWHZNUTRuQzdsSFdEMlYybmNwRTFteGlsaTlXVmJNOEZoX3U5dXUwMlBsZ0h2VFhBUlJZNHZwRnFmTHE4Qy1HY2k1?oc=5", "source_name": "Investing.com UK", "published_at": "2026-07-06T07:51:29+00:00", "published_display": "06 Jul 2026 07:51", "sentiment": "positive", "sentiment_pct": 66, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Tenet Healthcare Stock Jumps As Analysts Hold Buy Ratings Into Earnings", "summary": "", "url": "https://news.google.com/rss/articles/CBMiiAFBVV95cUxNYzlxZUxqQXJsWHRaUDE4SE1xeXUySXpBalJOamFXdlpnOHdQU25fTVFSdGZlcENQX2tLU2ljMXlvNW8xSnFNcHhsYnhJZURQSWNueTR4cVItWVdxbXFOeDNWYVRfOG9rWGpBNUUwT2lBSHVkcFdMdnhEUzdycnczUms3a3dzSDk5?oc=5", "source_name": "timothysykes.com", "published_at": "2026-07-04T15:08:00+00:00", "published_display": "04 Jul 2026 15:08", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Parabilis Medicines Inc. (PBLS) Stock Price | Live Quotes & Charts | NASDAQ", "summary": "", "url": "https://news.google.com/rss/articles/CBMiTkFVX3lxTE9DMmdCU2lwTTVuVmdWby1iaXVIX28tLU42MkRReHYtSlRQWW1IOGxCa245UlFkSmN1N2lTd2FRZVJ6azVPR2Fpb1VzR2dMUQ?oc=5", "source_name": "StocksToTrade", "published_at": "2026-07-03T00:53:00+00:00", "published_display": "03 Jul 2026 00:53", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Why Tenet Healthcare (THC) Stock Is Up Today", "summary": "", "url": "https://news.google.com/rss/articles/CBMipgFBVV95cUxNTGpMSWYxM2M3RmxZNHFVMm5pTnNfeTZKNzNiWHFJRTBkUDYtMWJaOFB0ZUVKYldFclQ2WFdscFJKTjdHS25XZVpMRE9CRUlSU3NDS3hKTUtaamxpREN2LTAyc3AtdWdTZlhzZ3kzYmEtMEI5QjVGZ0VVdFN2R0dKUWh2Vm9FelByMUU5N0tXQk5OeU5ZZndqekVNeEJVbHVZVTNUdmFB?oc=5", "source_name": "TradingView", "published_at": "2026-07-02T15:31:03+00:00", "published_display": "02 Jul 2026 15:31", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Insider Stock Purchases: June 29, 2026", "summary": "", "url": "https://news.google.com/rss/articles/CBMigAFBVV95cUxOYzVmX0h1OEhfQ1hmSC1ncThJMm1WSzE1alJQRDV3cmhsNDh4aHFHeDJjUEd3WjVid05qeW5sYVdrWmhEb2RoOTdtNVA4bktxb0ZmOHpPS08xR201ek80Z214Rmdhbk4zOWtnbGdGcTJTbUdhLTBMeGhjcF9iMTd4Xw?oc=5", "source_name": "Quiver Quantitative", "published_at": "2026-06-29T18:45:00+00:00", "published_display": "29 Jun 2026 18:45", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "[Form 4] Parabilis Medicines, Inc. Insider Trading Activity", "summary": "", "url": "https://news.google.com/rss/articles/CBMiuAFBVV95cUxPSndZX3hzUGJ5cUdyZmJIUFQ2Y2tvdUZ5ZHlqWUdraWpxRmNTSksyRHpqUTJkS19hUXJrMk9YWVZBVGJIcDI2VTkweUJlSEZfNEw0Vlk3OXhNOHEzLVVzVFF3WG53UUZOWmtUNmJWbTU2b0Jodld0Q1U3VHRCRHNHY2EzekdMNE1RSU52aXVPdDBwT1NzZFBuUEswb1lpbHZtTmlxSm9zbmh6RG1STnFMaHdaSzhjNnJZ?oc=5", "source_name": "Stock Titan", "published_at": "2026-06-29T14:41:50+00:00", "published_display": "29 Jun 2026 14:41", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Parabilis Medicines (PBLS) holder reports 527,070-share Series F position", "summary": "", "url": "https://news.google.com/rss/articles/CBMiywFBVV95cUxNcTBYMWg5TGUtazRUMHZ0X2lxSFJHc3Z6em5yOVJtS0tscEZMdE5PcjdHYjZ0VHlNZlhZeV9seWZ0Q2RQNGkxSzFJRUFENHI3TVhwb25wUmZ5RmExWkZ1SFBzYWk0QzlWVHVYajRvXzJuRmNkRVRob1pCX1NDUXRaY0xBMEtLcGh5YU5CVU1aeDZ2WmtNYXpNTnFlWk8xRzRnb0pGanVpTFpReGhjTUVDWkQxQ0xMNy1ucVl2VXp6STM0OFdzQW1Kc1Fidw?oc=5", "source_name": "Stock Titan", "published_at": "2026-06-29T14:38:50+00:00", "published_display": "29 Jun 2026 14:38", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Fresh Off IPO, A Director Buys $474,000 of Parabilis Medicines Stock. Is PBLS a Buy?", "summary": "", "url": "https://news.google.com/rss/articles/CBMizgFBVV95cUxOUzE5ZXV6WDUwS3hpSXZ2cUF1aGZnaE1nWmFiaE1fdWI1d2pDaXUxNE44MGs5c1ZrZVdrVkp3ai00bUZzcHNiMGNiNGhYZFpFazBkeHdnbmptdFJscXJFTmxKMURodElCS19PdkJ2WDNyLUp4NmtSRFgwRHd5cjltOUwwYk9XdDhteldnY0VjUG96MTA4WXFFSXIyWU8wNXBkaER2RkR4MFRNcTFsNHR2X2hsRktZNEFvRnhOcEFiNVVRMnBxVHRNakFSUGFiZw?oc=5", "source_name": "The Motley Fool", "published_at": "2026-06-20T07:00:00+00:00", "published_display": "20 Jun 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "[SCHEDULE 13D] Parabilis Medicines, Inc. Major Shareholder Acquisition (>5%)", "summary": "", "url": "https://news.google.com/rss/articles/CBMiygFBVV95cUxOMTBlV3Jid2NNUUF2ajM1Q0lxUDVBaUZRazU5R1drRFVZYUo1Y0Y5Z1dzTU1abzdKMEVNel94WG5jdGM0ZjZJUmNOQzRUUjhKUHNEcFpoU3lVcWJTaXIyOGxLMXdXcWpDSzhDeC1HWERZeDFubWZfRldTWkJ5RE1iRjRwS1VlQnZDbGFOSmJUTzBmUTFMRjBpLWNIcUpVOVktTGU1OU9PdFFlbjRPTDc5X0dCdktBSHFSM3BSSGdZaG1fQkpzdHZBSXNn?oc=5", "source_name": "Stock Titan", "published_at": "2026-06-18T07:00:00+00:00", "published_display": "18 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Apothecary Capital, tied to Parabilis (PBLS) director, buys 17,500 shares", "summary": "", "url": "https://news.google.com/rss/articles/CBMiuAFBVV95cUxOM3dWQzlJMGNEMUJULUxCMkduZjlnb2FGbmhremZ2VVBKSjhGdWNHRzZ1b2hlTDZvc1FZOWMzdkczSU94V3J2a0xQTThLaGp4VF9QZTllSVBqMDJwbFJCZ3MtRGxrM01DYVRsR3ZoRzFjS05pRHEzQmstUHpmV3BiaDNTU21KQTZBbXM2VGRhdGViQzlPc3AtZ203YnlTTzJ6WlZoRV9lUG54Uy01WElXcDR0VGQxcEo5?oc=5", "source_name": "Stock Titan", "published_at": "2026-06-16T07:00:00+00:00", "published_display": "16 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cooper Companies Stock: Is COO Underperforming the Healthcare Sector?", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqwFBVV95cUxPWkdoUDRJdkh3QndoZ3J2OHBvOEJlMUFEYjc1X3pLZGFXUlJ6eS1iNXhpYzNyd1NSZGxPOUdDM0xnZW9RcS1kdWNwR0xydVFVcEFGVmhfWWF5SFhYTmR5dXM0cTRIUENtbTc5bUpuNTNZQ0h0QWhMbnZDdGpfYjRWM2c3SWlCOHVJYTVoaUdDYnk2cTRKWWZTZHFvXzZDMTFmOGRUUUhyX3J6RUE?oc=5", "source_name": "Market source", "published_at": "2026-06-16T07:00:00+00:00", "published_display": "16 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Parabilis (PBLS) director-linked LLC makes open-market buy of 12,500 shares", "summary": "", "url": "https://news.google.com/rss/articles/CBMiuAFBVV95cUxQblp5MkxTMXptR0MzQWZYckJBby1vZktRSERnUWQ4cFQ3bzF4Wk5PdG1tMlNjeXBNVFRvOWthNXRBUXFwV29DV3BhMnQzcW5WbUZaOUhjWFVVS29pSThrY1dwZ3VVb3lQY2lKdVdsNjVjTEhvaGYzTkdEZldXbWVjZFRXcFU3ZHg2MzJsLTJ0aDBDUEw1RldKc1JrTjJ1VDJraVVuTTMzcUN6aDJEWms3amwyNTFwWVpo?oc=5", "source_name": "Stock Titan", "published_at": "2026-06-15T07:00:00+00:00", "published_display": "15 Jun 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "RA Capital funds lift Parabilis Medicines (PBLS) common equity exposure", "summary": "", "url": "https://news.google.com/rss/articles/CBMiuAFBVV95cUxQYzRCN0hrRlViRm10Y1BhQm9PSVN1Z2xOS1hZUEYyY3UzQ2ppb1k3UnNmaGNwSTF1OWlGUGV2Q0hhQmt1RXVxUjJ6ZktRRGJBNjE2SjdsSHBoTU0xbFlkMDZlV0JKS0V6ZFhyUjljQ0NGdXU5NHFBX3ZQeWhOX0hNRm1jLURINnlUdC1SeGU1NVg2ak5kM3QybXlIdDRyYlg2YzVFM2RYamdTS1hqbDJobnJlQ05GbGtv?oc=5", "source_name": "Stock Titan", "published_at": "2026-06-15T07:00:00+00:00", "published_display": "15 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Parabilis Medicines (PBLS) director converts preferred stock into common around IPO", "summary": "", "url": "https://news.google.com/rss/articles/CBMiuAFBVV95cUxOdjBJUTN5YVF6N19wTGU0OFQwVzdZQ1ZrQzRhWHBmRTVUWlBVZWZ6UlJQYldPVUVSbUJUN3NwMHZLVV94VHVuaTlDOW1NZTlJM0RaQmtEZ3kxV2h3Z2Z1RlZ3enZlN01fNDNfTktsYlctdWZuZFBHbDlWV2hiRXF6NjZ5RjFJVWkwejJJZmlVbjZHZDB5T1BVaTVSQUFnOV80d3A2SmNBLWx3UDExMW5PeWxQTzVlMEs5?oc=5", "source_name": "Stock Titan", "published_at": "2026-06-15T07:00:00+00:00", "published_display": "15 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Parabilis Medicines (PBLS) director converts Series F preferred into common in IPO", "summary": "", "url": "https://news.google.com/rss/articles/CBMiuAFBVV95cUxNNldIUXRFZEFaV09ua2NwNVl5LS1OeldaZkkzOURLd1FxNWxKR0NIVGxlX3RXVmh2RVNnLXhDWnhfcEFQd1o0RHo0aEpLa2dxcHEwUVdWc0NIamxUenRKbjVURGtSZzhYRUlDdUIyQUJ5Y0tYLWtFRW1DY1VlQnFMVTNKSXBYR0NPQTNLYXVNQVFEc1BMLTR3M2NwY25FZzU4dTFDNmdXSlJsNjZxTS11Mlo2UWg0bW40?oc=5", "source_name": "Stock Titan", "published_at": "2026-06-15T07:00:00+00:00", "published_display": "15 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Parabilis Medicines (PBLS) Stock Valuation After Recent 10% Single Day Decline", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqAFBVV95cUxQbU5qelItRGhjZkFHS29pMG9VMzA4WVBDNjZtaExhTXhiWU8yOWpuWEI5VzBWS2hmY2UzMTNQekJQOFVXR2NCZzBrTWpKaWFQLU1oaWJJc3dyanlMcFNMZi1TNE9IbndDMXViRmxJVDJJdjBKVk9rLWxYTDB6YjFwT1pOUzQ1TWdJcFFlbGhNb0ZwWWlzeG82TVVCbGgzUTJ4RUJJckVCNG8?oc=5", "source_name": "Market source", "published_at": "2026-06-15T07:00:00+00:00", "published_display": "15 Jun 2026 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Parabilis Medicines (PBLS) director granted 20,215 options at $20.00 strike", "summary": "", "url": "https://news.google.com/rss/articles/CBMiuAFBVV95cUxNaFVOQjhjQkIyblFfbGZHSlZndGhLVDVCVVd2MGg2MlZycTY3U0pEejhMdmFZY3l6emh6UVBNd1c2WU9idXN5Mk1Qa0M4aExlRmlra09iS2ZCNGJqdV9zUWQtbXZGZHNUcWN6OVZaVkNTNE9FZm9YMFZUOWtSZzhOdWlTMVRSclZHZUNuc29DM050a0I3WERzZVdXVnNPdmUwRmgzcXJxSWphRG9TRkVnWFdoOVpreVpy?oc=5", "source_name": "Stock Titan", "published_at": "2026-06-12T07:00:00+00:00", "published_display": "12 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Parabilis Medicines (PBLS) director receives stock options for 20,215 shares at $20", "summary": "", "url": "https://news.google.com/rss/articles/CBMiuAFBVV95cUxPZmtySDRGdGlMOGFoVEdCOFEyT1gyMkF2eVRTYlZaNEZwNi1vUEJuRExkRGVjNmNzYndXdGoxMjFfZDFkZzR6OGNBUnE1TF9WYkJtMmV0TTJfbjJ4LTdsUm84eWZHQ05TbWYwYjZOaGxvNzlxdEZTeGE3S0pZbmNjalFocTRlelk0Wmg4VXcyaGNyeUpIYjVaQ21uUF9saEJCYTk4Mk5oSFk1MHVuRTJmWFBDVWRSM2lV?oc=5", "source_name": "Stock Titan", "published_at": "2026-06-12T07:00:00+00:00", "published_display": "12 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Parabilis Medicines Closes Initial Public Offering", "summary": "", "url": "https://finance.yahoo.com/markets/stocks/articles/parabilis-medicines-closes-initial-public-203629656.html", "source_name": "MT Newswires", "published_at": "2026-06-11T20:36:29+00:00", "published_display": "11 Jun 2026 20:36", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Biotech Parabilis raises over $1.2B in 2026, backed by Regeneron", "summary": "", "url": "https://news.google.com/rss/articles/CBMiugFBVV95cUxObzROa3RHRU5zQmw2V3haRzJMRjZ2cTVqcExHTndkaHFtVExleFNuTzB1emJhV3g1TTJDWmxmLXAxODhYZEZnYUxGZXE2QVUzRmVXS2ZpRWlKNHVFaFp0MEZNMkVQUEFGSFN5WmxPb0VOWm5HQ0xLQmFTVVlCZWZtUElDVHZxa3g0TER3NWhjejVVb1ZUd2Z4RG56WU9MVXRyNE9aZGloeUFibThFaS1HMnAxWEQ1RV9Pd0E?oc=5", "source_name": "Stock Titan", "published_at": "2026-06-11T07:00:00+00:00", "published_display": "11 Jun 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Parabilis Medicines Announces Closing of Upsized Initial Public Offering, Including Full Exercise of Underwriters\u2019 Option to Purchase Additional Shares", "summary": "", "url": "https://news.google.com/rss/articles/CBMirwFBVV95cUxOUEtJT245cEdZRXFzeTV1c3lIS2hxSzF5cHpYdmdkSm9OV2pnelg3ZTFXbEdrTzlpNWR3UUo2d0RLYlVFbERaLXRJMFZsVUduajNqWVkzLWV4MThVajQ1WVZiWC1sS3ZUT3VpLWloeURRc3ZUSjkxYWFNeHlNME1kZ1FGYVc0aEllRmFvcDl0QkMwUzg2VDROOTBBOVpBbDlGWGh1N01UR2xOcWRMS05j?oc=5", "source_name": "Market source", "published_at": "2026-06-11T07:00:00+00:00", "published_display": "11 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "How to Play PBLS Stock After the Parabilis IPO", "summary": "", "url": "https://news.google.com/rss/articles/CBMilAFBVV95cUxOWnF5MlI3dkI0ZjdLZFJNazBwRFNMVTc2T2tnNDZsdnV5d20wUVV6QXZRQlpRVmVRMjIzX2Q4bEp1UkZoQU1fQzlIQlcwdnZJWjdESjdnSi1RbEdyMTB2YTk0ZDRIbzVLY3NJOVpMR3o0OEwweHJkWGEwSk9RZVN2SjA0UFpGbjJZYi1Dam02aTF1WVlo?oc=5", "source_name": "Barchart.com", "published_at": "2026-06-11T07:00:00+00:00", "published_display": "11 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Parabilis Reaches $3.7 Billion Market Cap on Frist Day Listed on NASDAQ", "summary": "", "url": "https://news.google.com/rss/articles/CBMijAFBVV95cUxOMHRoeHppV1hRakR2RkJEaHZDamxyb1Vyckg0Nk4wa3E5VFVOQ2dLYzNIdFRWQlBJa1ZEVTQtT2lPaUxScnEwUjJPeWw4R3pncmE5SUF5MEFBMTFiYnEyR29tb0l1VjFtUnBocGdIQWlnS3o1MTJuZWtNMThjSTBhMU1DOUg1SERQNHc5NA?oc=5", "source_name": "Pharmaceutical Executive", "published_at": "2026-06-11T07:00:00+00:00", "published_display": "11 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "PARABILIS MEDICINES (PBLS) Stock News & Updates", "summary": "", "url": "https://news.google.com/rss/articles/CBMiTkFVX3lxTFBHd2FyS016OUFuQUVEWXVCQzN6Y3FVRlZiVl9XOXZTeFZjVGhSc0xGY3VnQkhKa1RKclFocmJ6cjVTcjdmT0ttUS1FdHRKdw?oc=5", "source_name": "Stock Titan", "published_at": "2026-06-11T07:00:00+00:00", "published_display": "11 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "PARABILIS MEDICINES (PBLS) Stock Price, News & Analysis", "summary": "", "url": "https://news.google.com/rss/articles/CBMiU0FVX3lxTE83RmpwMXVzSU1fVThsMkhSR2FSVi0ydnFiRjYzMjRGc3p3SldfS3U3M2IzbWk1RXVKSTdFT1M1dTVzRzVBZWNsWmgwNktGY3dwUl9z?oc=5", "source_name": "Stock Titan", "published_at": "2026-06-11T07:00:00+00:00", "published_display": "11 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Parabilis Medicines to Raise $745 Million in IPO, Private Offering", "summary": "", "url": "https://finance.yahoo.com/markets/stocks/articles/parabilis-medicines-raise-745-million-100343602.html", "source_name": "MT Newswires", "published_at": "2026-06-10T10:03:43+00:00", "published_display": "10 Jun 2026 10:03", "sentiment": "positive", "sentiment_pct": 58, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "PBLS | Parabilis Medicines, Inc. Common Stock Data, Price & News", "summary": "", "url": "https://news.google.com/rss/articles/CBMiUEFVX3lxTE01d3hlU0V2SGMxOXd3LVo4SlN2alRhQnoyMEhtRHRRNVh1UGdVWXBqSGV2OXh2enhjNXZodUpySGVqTVlYQkh5VGtQaldHZktp?oc=5", "source_name": "Quiver Quantitative", "published_at": "2026-06-10T02:52:45+00:00", "published_display": "10 Jun 2026 02:52", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Drugmaker Parabilis Raises $745 Million in US IPO, Placement", "summary": "", "url": "https://news.google.com/rss/articles/CBMirgFBVV95cUxPWk9NMVlXMEZMemctdTZYbllzWDJENjd0OEE5VWh3VDlLRXgyNFp4NWhzSjlUM05PM3RvWEt4TU1iRjVNSjQwdDRTcHpQM0lyWGlrRE5vdkNkR2oxa3JCM2dKRlZ0QnEwWXdRTmplLUF2SDd4ZzJxNmFtQXhzNFdtS1c5UkFPdXY4UC1nbFdIS1BPM1dobHpMbkl3d1g3bWxIN1JMcFlsRTM2SVJKaXc?oc=5", "source_name": "Bloomberg.com", "published_at": "2026-06-09T07:00:00+00:00", "published_display": "09 Jun 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Parabilis Medicines Announces Pricing of Upsized Initial Public Offering", "summary": "", "url": "https://news.google.com/rss/articles/CBMirwFBVV95cUxQbHNwSkh4TWFlS0xrOUFrRzNHZUZ6V1hDZzRyN1V4aVEzYmdadmh6UlhSNmRCbTFrNHgwSlVWUWJOMnh1OHpaNkE4Y185LVBjMklfX3VNVFhhTWVzMlZLWG40NGtKMFBORlNSZnBkdUdIa2h3OHFQaXAzak1KWFVoTzNMUWd4ZWZlOUZ3Sy1WenJFYUxKVklEcUhxeldLdmZkYUl6TFoxZzQ0RHJKVDk4?oc=5", "source_name": "Market source", "published_at": "2026-06-09T07:00:00+00:00", "published_display": "09 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Parabilis Medicines targets $2.3 billion valuation in upsized US IPO", "summary": "", "url": "https://news.google.com/rss/articles/CBMiyAFBVV95cUxNSWg0QVVkWDZROWlCeEhXT05veEFkU0pRZ3JqcUNhdWRFb2hrUy1tRE1JelkzMDR6Tk1DVDNWV1NxSUZkUEtwbVNQVzFqT1ZlMzlWQUFTODI0dUxpSE8waHoySkw3dFdKbE1MekFBeTR4QzlFVmxCVFpzbWM0VWpnSjBodGczOUotcVZMNG9LcWc2N0tJRlI4RU5aU2tZMm5vZ0NGaUswRDFIMFJ6U0h2YXBYUXlVb0E5akZQOFdQc1JPOVYyZDE1VA?oc=5", "source_name": "Reuters", "published_at": "2026-06-09T07:00:00+00:00", "published_display": "09 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "symbol__ Stock Quote Price and Forecast", "summary": "", "url": "https://news.google.com/rss/articles/CBMiUEFVX3lxTE4xVVY3TFI3WF93SFNCTWU4YXRYa18zdkxxbWZIQlV6ZTVXNWItX0pBZzlVc2dTWHg2LTZBYzJISjktMjBxRlNYelY4Tkg4S1c3?oc=5", "source_name": "CNN", "published_at": "2026-06-05T20:49:49+00:00", "published_display": "05 Jun 2026 20:49", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "guidance", "event_label": "Guidance", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Parabilis Medicines aims to raise up to $475 million in US IPO", "summary": "", "url": "https://news.google.com/rss/articles/CBMiwgFBVV95cUxQcnZyenBRbkNCcl90TG5GeU5GVE8yM18wNDg1UFdISE5PUHl2VVZaRzN0MXgyWmVxOEpBd2tmaDRzNVRxS29aZzZfa1VkX0RLdW5BekR2c2g5Q3pLa25uWE1TdGZFcGNJS0g0REJTQ2VlVDNBYnBidXI1ZFFKVkJiNjJ0d0wyeDV5U2VMMDVyakdYMUVQOEZXcXA3VF9OVGZQX2hqdzZXTDdfbGV2eVR3Y1REUjNfZmlMWThSOWRmN2Fldw?oc=5", "source_name": "Reuters", "published_at": "2026-06-04T07:00:00+00:00", "published_display": "04 Jun 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Regeneron backed Parabilis seeks up to $476M in U.S. IPO", "summary": "", "url": "https://news.google.com/rss/articles/CBMiigFBVV95cUxPQ3BjNmZBM2N5OHdpZEFvN0Jhd3VveU5BWHZuc3ZMX1UwU25ueThnckFFT0tNWk1IM21nbFJZOHpodlRUZmtpU25rUkRYZEpSVU1FSmNJaUxtSWJmMFRVQXMtamJQX2hsd25BaXEyUlFoZ0ZnZmFpSE1XUGVFMVo4YmE3MmIxdl9YM1E?oc=5", "source_name": "Seeking Alpha", "published_at": "2026-06-04T07:00:00+00:00", "published_display": "04 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "UNH stock jumps on Q1 earnings beat and raised guidance to $18.25+", "summary": "", "url": "https://news.google.com/rss/articles/CBMimAFBVV95cUxPTEprdzNMNGZxdkg5Wll5MTlvS1dheXQybm14TERTcGVzcHQzY0llOEpTa0dpZ1hGdHVyNWZ2cFFiWmZRdkl1aUp4YVlTMVJxSDRzaEdzRFB1cW93QzdhSmNxcEZDMWhGX2F0ODJFcjY1Mk1kMVhLNnVJSUhVMHZpRjRtTHo2cXBvbVJ3a05SWlJNMUdrSzFPbA?oc=5", "source_name": "eciks.org", "published_at": "2026-05-26T07:00:00+00:00", "published_display": "26 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 84, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Regeneron backed Parabilis Medicines seeks U.S. IPO", "summary": "", "url": "https://news.google.com/rss/articles/CBMigwFBVV95cUxOTFJBMkJLUTRVUk9QXzdEWV9SSE5WNS1ZYjNNYkk3UEJaSGdZUHAxaUFYVEpaOGFPRV96aWdUeWZzUXo5RWs3clNuSTdGYkRFaVhDWnhNeVE0MnBoMFg1OGVSNDJRVGk5WUgyR0l3X3pVRXVfREExMDdKZU5UMklQMXJEOA?oc=5", "source_name": "Seeking Alpha", "published_at": "2026-05-20T07:00:00+00:00", "published_display": "20 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "UnitedHealth Group Stock Soars on Strong Earnings, Boosted Outlook", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqwFBVV95cUxOREJZdE9YcDdTNFFiaGZpWWhZdkFleGdCT0lkdlBXMk5MRXRJV3VGODItT052ZDhGNjNxM3JYaW5nTllpNW8yOVplVWdBQjZkTWNXWVNRZklWQi1PTU93MGotVWtEd2VhUVJyZFBEbXdwTDFrTUdGWXV0MHUyOXJ2a3lWclFQNE1TNzZGd3ZqTnJOdlRHRFp3aEgxOTJJcTdlYTJIYldJMTdlRFk?oc=5", "source_name": "Investopedia", "published_at": "2026-04-21T07:00:00+00:00", "published_display": "21 Apr 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "How Much Is UnitedHealth Group Stock Expected to Move After Earnings?", "summary": "", "url": "https://news.google.com/rss/articles/CBMirwFBVV95cUxPZjhXN2wySGd0T0g2am9uTU9YZWFMdDV5d0pfWEw5SWFrR3hCbXdJTER5WEFOUWt1LW9kWDdOV2w3ZEhxOWtKeDQxMkc1ZWRBb0gyT095dkI0UmJhR1hubWtfNk5zS0t6ejBSbkpNZ2t5eXY0QUlBNmx5LVZzN3JWSzBTN1I4N2x3Sk9TRkpYMXV6bTNTUlZRSzctR041Wlh4Z2VTcHdGTFppTkx3VHVV?oc=5", "source_name": "Investopedia", "published_at": "2026-04-17T07:00:00+00:00", "published_display": "17 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Puma Biotechnology Stock Declines More Than 9% in a Month: Here's Why", "summary": "", "url": "https://news.google.com/rss/articles/CBMijAFBVV95cUxNTTJZRVF4TFNBb3BhMW9VUnBnMVZhenZLNlZJY3Ryc3pGZ3dhZXBDY3pId0I5NFdmVTdiR2EyNXNBZFFuQ1M2M3pUTlRZdXJkbGxaT29mWm4wTG5fU2RtV1hIZWRwZUVNb3BEbTZKX3NPRV9mZVpiY3JBZDdMSDRveW1Jb0lIVmRKLVlidA?oc=5", "source_name": "Market source", "published_at": "2026-03-18T07:00:00+00:00", "published_display": "18 Mar 2026 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Why Did Puma Biotechnology's Stock Plummet Despite Beating Q4 Estimates", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqgFBVV95cUxQUEQ4TXY0R1lWMTJIcEJySm5iaEl1UkJ6TDMxcUtQYVl3UmxYdlJnaElpdlJDLU0xTTRvT0dsellqX21Tc3lxWW9IbWxHMnFBZGlxajdnUUU2OTNVY0l3NUh0OExMUENwWGxqY1d5dXV3YmRDZm9IRzc1c3FjbUh2cGxvdEJMZ25lYXdjSUliZ0txSjVFOHJhUXNTajBLeVV0M3B4dDk4V3dfQQ?oc=5", "source_name": "Kavout | AI", "published_at": "2026-02-28T09:53:07+00:00", "published_display": "28 Feb 2026 09:53", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Vir Biotechnology Stock Skyrockets 65% on Positive Prostate Cancer Treatment Trial Results", "summary": "", "url": "https://news.google.com/rss/articles/CBMivwFBVV95cUxNeEtXZ1k1WGctLWZuX0tYZE5SLWN4MU5KUktLV3NobzVheFpoMkZhdFJrWTdNelAwWGxYZUswazZtMWFUaXEzY3k0QnI0TW9IMGc2UTNzUlNmR1JxZG1JbEpQM0N3N1p4blRjaGdvMExoZzJOYWF3Tk5hajJCTlprZ3dESTVEd0Y4TXhvcElNR3Bqemd3RmNKcGxwa2dSU2phak9paE53c0t3dVFVeGZic2liZ1I0UU80TEM2WUNlOA?oc=5", "source_name": "TIKR.com", "published_at": "2026-02-25T08:00:00+00:00", "published_display": "25 Feb 2026 08:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "This Small-Cap Biotech Stock Is Soaring 29% on Excitement Over Its Prostate Cancer Drug", "summary": "", "url": "https://news.google.com/rss/articles/CBMimwFBVV95cUxPSG1pQzVIRmhqTkhiWXozT29mTWM0UERfakxmOTZzdm5TZ24wZTVqLUpSWlFyWGVmYnlicGE3ZVYxOVotWU5naGM5aUZVakItUGJLTk1ZVE1mclRHd1N3N0FIWkV2TzFrT2lMNFRjcHhnVVBzTk5vNUFkLTgwNExtRWJYN1hVZzRkVjRlTktkNk1jcnpfQklCamN3NA?oc=5", "source_name": "Barron's", "published_at": "2026-02-24T08:00:00+00:00", "published_display": "24 Feb 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "industry": [{"title": "There May Be Reason For Hope In Puma Biotechnology's (NASDAQ:PBYI) Disappointing Earnings", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-05-15T07:00:00+00:00", "published_display": "15 May 2026 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Puma Biotechnology's (NASDAQ:PBYI) Conservative Accounting Might Explain Soft Earnings", "summary": "", "url": "https://news.google.com/rss/articles/CBMirgFBVV95cUxNZXcyN1VKc0J0RTFtSER6TGRSZm8xSWs2c0paem5paDd3V0J1cjF6ajhFb29tRFpUWWpxYUhzZjFkSXhYQ0lBNTVlbTdCRERpSXNjaGpDajFPOVlpRS1qV2xHMTRHS2pjVVBZMWFfNzItWE9FeENtQ2duMUxVQm5kOG41eVlrNUpObXp2VlhfekdhMVh2X0hjN3ZFZThZNUdWakFLUXJ4aFBVN2JyR2c?oc=5", "source_name": "Market source", "published_at": "2026-05-14T07:00:00+00:00", "published_display": "14 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Earnings Update: Here's Why Analysts Just Lifted Their Puma Biotechnology, Inc. (NASDAQ:PBYI) Price Target To US$5.00", "summary": "", "url": "https://news.google.com/rss/articles/CBMingFBVV95cUxPSUN3RjZYMEJ2VUdKQjJpRkZaUXRzM2NTa05WWmlmWHJnZDlJeUpTdFM5Wmk0SUhjclU2dldTZFIyRmZZeGJSNGM2SUNiSGJSYjh1VjYyR0hPZ2FJbWdsbHExYlhwMW1HRTZ0NUxwQzU1b2g4MGpwSHdoMkdIOUtqOXBBYk92LVk2cEFZMzVISjB3c04ydVBEYWw2cVVsdw?oc=5", "source_name": "Market source", "published_at": "2026-05-11T07:00:00+00:00", "published_display": "11 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Q4 Earnings Highlights: Regeneron (NASDAQ:REGN) Vs The Rest Of The Biotechnology Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMirAFBVV95cUxNWW9GYm5uRzlBX2ZiZXA3RkdDXzJhaFd2N1ZwR21jaXhiRkZQSTNHT0hMaUFjSGl6VXZfOURKemF2bWlFS1hKTXBjZUw4amdVQ0I4QlVnNmFkY1VTQ25pUjBiZGNDUE9QdWdOZHAxV1I1ejN6UE9WdGpseUdrMVA5MXBXWXJmWDBkZUdWUkxpOURCdlZlbDlQR3M5cjAzaDFtakFNblRTa3c0Q1J6?oc=5", "source_name": "Market source", "published_at": "2026-04-25T07:00:00+00:00", "published_display": "25 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Biotechnology Stocks Q3 Results: Benchmarking Natera (NASDAQ:NTRA)", "summary": "", "url": "https://news.google.com/rss/articles/CBMiswFBVV95cUxPZzZDSEhwNlVYQU9kNXBMMU5ia0FTU0RxRlYwb0I1RERNODN4N0VwRFZWMUY4ODh3eWNkTkp0UERreFlSTllocGk4a2ZKcGlJVjQ4d1dXWlNnYTc5UlNMZm4wc2xITjRQVzhRb3Z5LXllQmhvUHNIaXB3LXk1RUw1WnRPam9wcVE1MXFxSmVzVF9MVmRyMWIwdVkxS1N3MUJZUzByLWxrVDlSSUk4QnNsXzJYbw?oc=5", "source_name": "Market source", "published_at": "2026-04-21T07:00:00+00:00", "published_display": "21 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "A Look Back at Biotechnology Stocks\u2019 Q4 Earnings: Incyte (NASDAQ:INCY) Vs The Rest Of The Pack", "summary": "", "url": "https://news.google.com/rss/articles/CBMipAFBVV95cUxNZXlTZHFHZVNxMktqZ0hVNURmdE1hUFpZZnlfdEVhMnVla2EyTWN6b2YwNkVhNllxUy1Bczl2a0ZUNk04Q3oyTEZSajdpMnFDVXJfRTlfLUdHQ05uS3FQZkhNWkJ0MDFENDJvRXR0ZGV1RDlYVmdWem96V29NeTg4YWRZWGNoMzM1emRoSExJbXdwZnJIWHpsYjVnT0FQVHZtUW5iVg?oc=5", "source_name": "Market source", "published_at": "2026-03-30T07:00:00+00:00", "published_display": "30 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "With EPS Growth And More, Puma Biotechnology (NASDAQ:PBYI) Makes An Interesting Case", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2025-12-09T08:00:00+00:00", "published_display": "09 Dec 2025 08:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}], "sector": []}, "total_fetched": 76, "total_relevant": 52, "sentiment_summary": {"positive": 15, "negative": 3, "neutral": 34, "score": 55, "total": 52, "label": "Balanced news tone", "tone": "neutral"}, "classifier": {"primary_event": "general", "primary_label": "Market update", "confidence": 84, "events": [{"event": "general", "label": "Market update", "weight": 20.8, "count": 34}, {"event": "earnings", "label": "Earnings", "weight": 5.64, "count": 12}, {"event": "analyst", "label": "Analyst action", "weight": 1.65, "count": 3}, {"event": "guidance", "label": "Guidance", "weight": 1.1, "count": 2}, {"event": "deals", "label": "Deals and strategy", "weight": 0.55, "count": 1}], "positive_events": 15, "negative_events": 3}, "market_context": {"has_market_context": true, "latest_close": 29.58, "latest_week": "2026-07-03", "one_week_move": 2.7, "four_week_move": null, "twelve_week_move": null, "trend_signal": "0", "trend_label": "Trend inactive", "trend_tone": "negative", "market_dynamics": 0.0, "market_dynamics_buy_signal": false, "relative_strength": null, "fair_value_gap": 6.1, "fair_value_label": "Near fair-value range", "fair_value_tone": "neutral", "expectation_direction": "undecided", "expectation_probability": 50.0, "reaction_label": "Price confirming higher", "reaction_tone": "positive", "market_sentence": "+2.7% over one week, - over four weeks, trend inactive, and near fair-value range."}, "interpretation": {"label": "Balanced read", "tone": "neutral", "classification": "balanced", "summary": "News tone and price action are not far from neutral.", "confidence": 65, "badges": [], "opportunities": [], "risks": [], "event_label": "Market update", "sentiment_word": "balanced"}, "charts": {"sources": [{"label": "Stock Titan", "count": 13}, {"label": "Market source", "count": 10}, {"label": "Quiver Quantitative", "count": 2}, {"label": "MT Newswires", "count": 2}, {"label": "Reuters", "count": 2}, {"label": "Seeking Alpha", "count": 2}, {"label": "simplywall.st", "count": 2}, {"label": "Investopedia", "count": 2}], "tiers": [{"label": "Direct company coverage", "count": 45}, {"label": "Industry context", "count": 7}, {"label": "Sector context", "count": 0}], "events": [{"label": "Market update", "count": 34}, {"label": "Earnings", "count": 12}, {"label": "Analyst action", "count": 3}, {"label": "Guidance", "count": 2}, {"label": "Deals and strategy", "count": 1}]}, "insights": [{"label": "Weighted tone", "value": "55/100", "tone": "neutral", "text": "Balanced news tone"}, {"label": "Market reaction", "value": "Balanced read", "tone": "neutral", "text": "News tone and price action are not far from neutral."}, {"label": "Primary event", "value": "Market update", "tone": "neutral", "text": "84/100 classification confidence."}, {"label": "Company focus", "value": "45", "tone": "positive", "text": "directly relevant articles"}, {"label": "Source quality", "value": "6", "tone": "positive", "text": "high-authority source matches"}, {"label": "Trend context", "value": "Trend inactive", "tone": "negative", "text": "+2.7% over one week, - over four weeks, trend inactive, and near fair-value range."}, {"label": "Latest direct headline", "value": "Neutral", "tone": "neutral", "text": "PBLS Stock: Price, Forecast, Financials & AI Analysis"}], "updated_at": "2026-07-08T05:17:32.760892+00:00", "disclaimer": "Educational market research only. Not financial, investment, trading, tax, or legal advice."}